EP1549951A4 - Proteines de type semaphorine et methodes d'utilisation de celles-ci - Google Patents

Proteines de type semaphorine et methodes d'utilisation de celles-ci

Info

Publication number
EP1549951A4
EP1549951A4 EP03739026A EP03739026A EP1549951A4 EP 1549951 A4 EP1549951 A4 EP 1549951A4 EP 03739026 A EP03739026 A EP 03739026A EP 03739026 A EP03739026 A EP 03739026A EP 1549951 A4 EP1549951 A4 EP 1549951A4
Authority
EP
European Patent Office
Prior art keywords
semaphorin
proteins
methods
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03739026A
Other languages
German (de)
English (en)
Other versions
EP1549951A2 (fr
Inventor
Enrique Alvarez
David W Anderson
Mohanraj Dhanabal
Nikolai V Khramtsov
William J Larochelle
Henri S Lichenstein
Li Li
Chean Eng Ooi
Muralidhara Padigaru
Richard A Shimkets
Mei Zhong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/403,676 external-priority patent/US20040029150A1/en
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of EP1549951A2 publication Critical patent/EP1549951A2/fr
Publication of EP1549951A4 publication Critical patent/EP1549951A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP03739026A 2002-05-30 2003-05-30 Proteines de type semaphorine et methodes d'utilisation de celles-ci Withdrawn EP1549951A4 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US403676 1995-03-14
US38479802P 2002-05-30 2002-05-30
US384798P 2002-05-30
US40240702P 2002-08-09 2002-08-09
US402407P 2002-08-09
US44306203P 2003-01-28 2003-01-28
US443062P 2003-01-28
US10/403,676 US20040029150A1 (en) 1999-03-09 2003-03-31 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
PCT/US2003/017412 WO2003102584A2 (fr) 2002-05-30 2003-05-30 Proteines de type semaphorine et methodes d'utilisation de celles-ci

Publications (2)

Publication Number Publication Date
EP1549951A2 EP1549951A2 (fr) 2005-07-06
EP1549951A4 true EP1549951A4 (fr) 2006-08-09

Family

ID=29716299

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03739026A Withdrawn EP1549951A4 (fr) 2002-05-30 2003-05-30 Proteines de type semaphorine et methodes d'utilisation de celles-ci

Country Status (5)

Country Link
EP (1) EP1549951A4 (fr)
JP (1) JP2005528434A (fr)
AU (1) AU2003245387A1 (fr)
CA (1) CA2487939A1 (fr)
WO (1) WO2003102584A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090227518A1 (en) * 2005-12-02 2009-09-10 The Regents Of The University Of Colorado Compositions and methods for treating actin-mediated medical conditions
NZ578816A (en) * 2007-02-02 2012-06-29 Biogen Idec Inc Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000031252A1 (fr) * 1998-11-26 2000-06-02 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Semaphorine humaine 6a-1(sema6a-1), gene implique dans des mecanismes de developpement et de regeneration neuronaux pendant l'apoptose, et son utilisation en tant que cible potentielle de medicaments
WO2000053742A2 (fr) * 1999-03-09 2000-09-14 Curagen Corporation Polynucleotides et proteines codees par ceux-ci
US20030054514A1 (en) * 1999-03-09 2003-03-20 Shimkets Richard A. Novel polynucleotides and proteins encoded thereby
WO2003085096A2 (fr) * 2002-04-01 2003-10-16 Curagen Corporation Polypeptides therapeutiques, acides nucleiques les codant et leurs procedes d'utilisation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000031252A1 (fr) * 1998-11-26 2000-06-02 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Semaphorine humaine 6a-1(sema6a-1), gene implique dans des mecanismes de developpement et de regeneration neuronaux pendant l'apoptose, et son utilisation en tant que cible potentielle de medicaments
WO2000053742A2 (fr) * 1999-03-09 2000-09-14 Curagen Corporation Polynucleotides et proteines codees par ceux-ci
US20030054514A1 (en) * 1999-03-09 2003-03-20 Shimkets Richard A. Novel polynucleotides and proteins encoded thereby
WO2003085096A2 (fr) * 2002-04-01 2003-10-16 Curagen Corporation Polypeptides therapeutiques, acides nucleiques les codant et leurs procedes d'utilisation

Also Published As

Publication number Publication date
WO2003102584A2 (fr) 2003-12-11
EP1549951A2 (fr) 2005-07-06
JP2005528434A (ja) 2005-09-22
CA2487939A1 (fr) 2003-12-11
AU2003245387A1 (en) 2003-12-19
WO2003102584A3 (fr) 2004-02-19

Similar Documents

Publication Publication Date Title
EP1501514A4 (fr) Modulateurs de proteine-kinases et leurs methodes d'utilisation
EP1546112A4 (fr) Imidazolopyridines, procedes de fabrication et methodes d'utilisation
EP1660013A4 (fr) Biomateriaux et biocoacervats proteiniques, leurs procedes de fabrication et d'utilisation
EP1465615A4 (fr) Derives de bis- enone tricyclique et methodes d'utilisation
HK1079789A1 (zh) 血管靜態毒性試劑及其使用方法
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
AU2003275311A1 (en) Solid micro-perforators and methods of use
EP1660638A4 (fr) Lipoparticules comprenant des proteines, et procedes de production et d'utilisation de ces lipoparticules
AU2003267124A8 (en) Bh3 peptides and method of use thereof
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
AU2003224890A1 (en) Drug-complex microparticles and methods of making/using same
EP1476150A4 (fr) Carboxyfullerenes et procedes d'utilisation de ceux-ci
EP1578917A4 (fr) Proteines multimeres et methodes de production et d'utilisation de ces proteines
AU2003215244A8 (en) Complexes and methods of using same
EP1491091A4 (fr) Moyen de resistance aux insectes et procede de resistance aux insectes
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2003252026A8 (en) Npc1l1 (npc3) and methods of use thereof
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003282338A8 (en) Determination of protein function
EP1545287A4 (fr) Composes vasoregulateurs et procedes concernant leur utilisation
AU2003216354A8 (en) Modulators of paraptosis and related methods
AU2003222533A1 (en) Proteins with deglycating activities and methods of using same
EP1549951A4 (fr) Proteines de type semaphorine et methodes d'utilisation de celles-ci
EP1452597A4 (fr) Procede d'activation de proteine
AU2003220085A8 (en) Protein a compositions and methods of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041130

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CURAGEN CORPORATION

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/16 20060101ALI20051221BHEP

Ipc: C07K 14/47 20060101ALI20051221BHEP

Ipc: C12N 15/62 20060101AFI20051221BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20060706

17Q First examination report despatched

Effective date: 20070109

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070720